By Bret Jensen:I have been accumulating Teva Pharmaceuticals (TEVA) for a few months. I think is it is solid bargain given its low valuation as well as its solid earnings and revenue growth prospects. As we get closer to year end, I believe it is a great time to pick up more shares or established a position in the stock.
3 Key catalysts for Teva Pharmaceuticals
1. The stock is down some 25% for the yearComplete Story »
Teva Pharmaceuticals: A Great Year End Buy
Fri, 12/09/2011 - 2:22pm
